| 12 Aug 2026, 18:27 | Orthocell Canaccord Genuity Conference Live Webcast | Presentations | — | 14014 |
| 11 Aug 2026, 18:45 | Orthocell to Present at Canaccord Growth Conference | Presentations | — | 03026 |
| 3 Aug 2026, 18:38 | Change of Registered Office & Principal Place of Business | Securities Administration | — | 12002, 12003 |
| 21 July 2026, 04:10 | Appendix 3Y - John Van Der Wielen | Director Interests | — | 02009 |
| 21 July 2026, 04:06 | Application for quotation of securities - OCC | Other | — | 06020 |
| 18 July 2026, 02:42 | Appendix 3Y x 4 | Director Interests | — | 02009 |
| 18 July 2026, 02:36 | Application for quotation of securities - OCC | Other | — | 06020 |
| 17 July 2026, 23:31 | Notification regarding unquoted securities - OCC | Other | — | 06021 |
| 17 July 2026, 23:30 | Notification regarding unquoted securities - OCC | Other | — | 06021 |
| 17 July 2026, 20:07 | Option Terms and Conditions | Securities Administration | — | 06009 |
| 17 July 2026, 20:03 | Proposed issue of securities - OCC | Securities Administration | — | 06013 |
| 16 July 2026, 23:43 | Notification of cessation of securities - OCC | Other | — | 06027 |
| 14 July 2026, 18:47 | Q4 FY26 ASX Investor Presentation | Presentations | MS | 03026, 19009 |
| 13 July 2026, 18:53 | Quarterly Activity Report & Appendix 4C | Quarterly Reports | MS | 19004, 19009 |
| 6 July 2026, 18:43 | Orthocell Investor Webinar Details | Other | — | 03027 |
| 3 July 2026, 18:56 | Orthocell Appoints Thailand Distributor for Remplir | Company Update | MS | 11001 |
| 30 June 2026, 18:51 | Clinical Outcomes See Expanded Use of Remplir in the Ukraine | Company Update | — | 11001 |
| 15 May 2026, 02:15 | Cleansing Notice | Securities Administration | — | 06018 |
| 15 May 2026, 02:11 | Application for quotation of securities - OCC | Other | — | 06020 |
| 6 May 2026, 02:22 | Cleansing Notice | Securities Administration | — | 06018 |
| 6 May 2026, 02:19 | Application for quotation of securities - OCC | Other | — | 06020 |
| 4 May 2026, 19:39 | Appendix 3Y - Michael McNulty | Director Interests | — | 02009 |
| 4 May 2026, 19:36 | Appendix 3Y - John Van Der Wielen | Director Interests | — | 02009 |
| 30 Apr 2026, 19:14 | First Sales of Remplir Achieved in US$75m Canadian Market | Company Update | MS | 11001 |
| 28 Apr 2026, 19:10 | Compelling 90% Success Rate for Remplir in Real World Study | Company Update | MS | 11001 |
| 20 Apr 2026, 19:05 | Q3 FY26 Investor Presentation | Presentations | MS | 03026 |
| 20 Apr 2026, 19:04 | Quarterly Activity Report & Appendix 4C | Quarterly Reports | MS | 19003, 19008 |
| 17 Apr 2026, 19:01 | First Surgical Use of Remplir in US Department of Defense | Company Update | MS | 11001 |
| 15 Apr 2026, 19:00 | OCC Secures Access to 221 U.S. Military Medical Centres | Company Update | MS | 11001 |
| 15 Apr 2026, 18:25 | Notification of cessation of securities - OCC | Other | — | 06027 |
| 14 Apr 2026, 20:20 | Orthocell Investor Webinar Details | Presentations | — | 03027, 14014 |
| 8 Apr 2026, 19:06 | US Section 232 Tariffs Not Expected to Affect Remplir | Company Administration | — | 12008 |
| 1 Apr 2026, 01:43 | Orthocell Investor Presentation - Broker Meets Biotech | Presentations | — | 03026 |
| 18 Mar 2026, 20:57 | Remplir Used in 23 Surgeries in Ukrainian soldiers | Company Update | MS | 11001 |
| 17 Mar 2026, 06:29 | Notification of cessation of securities - OCC | Other | — | 06027 |
| 17 Mar 2026, 05:34 | Notification regarding unquoted securities - OCC | Other | — | 06021 |
| 10 Mar 2026, 20:08 | Orthocell Appoints UK Distributor for Remplir | Company Update | MS | 11001 |
| 26 Feb 2026, 19:47 | Appendix 3Y - Michael McNulty | Director Interests | — | 02009 |
| 26 Feb 2026, 19:46 | Appendix 3Y - John Van Der Wielen | Director Interests | — | 02009 |
| 24 Feb 2026, 20:02 | Appendix 4D & Half-Year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 |
| 18 Feb 2026, 23:56 | Orthocell Receives $3.0m R&D Tax Refund | Periodic Reports | MS | 03014 |
| 2 Feb 2026, 20:02 | US Market and Operational Update | Presentations | MS | 03026, 03028 |
| 29 Jan 2026, 21:21 | Orthocell Investor Webinar Details | Presentations | — | 14014 |
| 19 Jan 2026, 20:07 | Quarterly Activity Report & Appendix 4C | Quarterly Reports | MS | 19002, 19007 |
| 16 Jan 2026, 20:01 | Orthocell Finalises Strategic Investment in Marine Biomedica | Company Update | — | 11001 |
| 6 Jan 2026, 20:33 | Orthocell Posts Seventh Straight Record Revenue Quarter | Company Update | MS | 03014, 11001 |
| 23 Dec 2025, 05:10 | Appendix 3Y - Paul Anderson | Director Interests | — | 02009 |
| 23 Dec 2025, 05:06 | Cleansing Notice | Securities Administration | — | 06018 |
| 23 Dec 2025, 05:04 | Application for quotation of securities - OCC | Other | — | 06020 |
| 18 Dec 2025, 20:42 | Orthocell Hits US Milestone - 100 Remplir Units Sold. | Company Update | MS | 11001 |